EU drug safety surveillance project announces new measures
This article was originally published in SRA
The European Medicines Agency -led pharmacoepidemiology and pharmacovigilance initiative, ENCePP, has put in place a new process to facilitate interaction between ENCePP partners and third parties, including pharmaceutical companies1.
You may also be interested in...
Five new drugs have been recommended for EU approval at the latest meeting of European Medicines Agency’s drug evaluation committee.
The European Commission has set aside, for now, concerns expressed by member states regarding the scope of medicines subjected to additional monitoring requirements.
A new work sharing pilot has been launched to evaluate jointly generic drugs intended for launch in Singapore and Malaysia.